Lucid DiagnosticsLUCD
13F holders, Q1 2024 (March 31)30holders
1famous investor
$0.81avg. 13F price*
At the end of Q1 2024, 30 institutions reported holding Lucid Diagnostics Inc. (LUCD) in their 13F filings. The largest holders were Luminus Management LLC ($581K), Vanguard Group Inc. ($454K) and Nantahala Capital Management, LLC ($132K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Lucid Diagnostics Inc.
- CUSIP
- 54948X109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $66K |
| Exits | 4 | $209K |
Ownership 30 holders
| Luminus Management LLC | 0.26% | Reduce -7.2% | 717,657 | $581K |
| Vanguard Group Inc. | 0.00% | Add +68.8% | 560,915 | $454K |
| Nantahala Capital Management, LLC | 0.01% | No change | 149,698 | $132K |
| Geode Capital Management, LLC | 0.00% | Add +18.1% | 155,757 | $126K |
| Jane Street Group, LLC | 0.00% | Add +888.4% | 122,013 | $99K |
| HRT Financial LP | 0.00% | New | 63,035 | $51K |
| BlackRock Inc. | 0.00% | Add +120.2% | 51,646 | $42K |
| Verition Fund Management LLC | 0.00% | Add +17.2% | 42,379 | $34K |
| LPL Financial LLC | 0.00% | Add +13.5% | 37,032 | $30K |
| Virtu Financial LLC | 0.00% | Add +66.4% | 34,671 | $28K |
| Geneos Wealth Management Inc. | 0.00% | No change | 33,850 | $27K |
| Citadel Advisors | 0.00% | Reduce -1.1% | 29,301 | $24K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1867.8% | 19,973 | $16K |
| State Street Corp. | 0.00% | Add +75.2% | 18,428 | $15K |
| Wells Fargo & Company | 0.00% | Add +59.7% | 14,505 | $12K |
| Northern Trust Corp. | 0.00% | New | 13,145 | $11K |
| Jones Financial Companies LLLP | 0.00% | New | 3,831 | $3K |
| Cwm, LLC | 0.00% | New | 1,761 | $1K |
| Morgan Stanley | 0.00% | Add +388.0% | 976 | $790 |
| CIBC Private Wealth Group LLC | 0.00% | New | 315 | $283 |
| Allworth Financial LP | 0.00% | New | 157 | $128 |
| NFSG Corp | 0.00% | New | 50 | $40 |
| Osaic Holdings, Inc. | 0.00% | Reduce -97.8% | 45 | $35 |
| JPMorgan Chase & Co. | 0.00% | Reduce -27.7% | 34 | $28 |
| M&R Capital Management Inc. | 0.00% | New | 25 | $20 |
| Bank of America Corp. | 0.00% | Reduce -78.6% | 3 | $3 |
| Thompson Investment Management, Inc. | 0.00% | New | 1 | $1 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -99.0% | 1 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -55.0% | 89 | $0 |
| Hantz Financial Services, Inc. | 0.00% | No change | 10 | $0 |
"% of holder's portfolio" is LUCD's weight in each manager's 13F, not the share of Lucid Diagnostics Inc. the manager owns.